Justin Hartley backed Chrissy Metz and her GLP-1 decision in an interview on Monday, 17 August 2026, telling a reporter his former This Is Us co-star was wonderful and that he loves her dearly.
Metz had gone public days earlier with the news that she was using GLP-1 medication as part of a wider health push, as reported by Us Weekly. Hartley was asked about it directly and did not hesitate.
What Justin Hartley said about Chrissy Metz and GLP-1
Hartley played Kevin Pearson opposite Metz’s Kate on the NBC family drama, siblings whose relationship carried a good chunk of the show across its six seasons.
Asked what he made of her news, he answered without any hedging:
“She’s wonderful. She knows what I think of her. She’s terrific. And anytime I hear her doing well in any way, shape, or form is a great thing for me because I love her. I love her dearly.”
This Is Us ended in 2022 after six seasons, and Hartley’s answer read less like a publicist’s line and more like a brother checking in. He did not go into detail about Metz’s treatment, and he did not need to.
The affection did the work on its own.
Why Chrissy Metz shifted on GLP-1 medication
Metz held out for a long stretch before a friend talked her round. Speaking in a television interview on Monday, 10 August 2026, she said she had been “very skeptical of GLP-1s for like years” before changing her position on the medication.
She has since become a brand ambassador for telehealth company Ro and has lost 63 pounds, roughly 29 kilograms, since starting. The number was hers to share, and she shared it rather than letting the speculation run without her.
Kate Pearson’s weight was written into This Is Us from the pilot, and Metz spent six seasons fielding questions about her body in a way few of her co-stars faced.
That history is part of why her decision landed the way it did, and why the reaction to it was watched so closely.
Where Justin Hartley and Chrissy Metz stand now
GLP-1 medications were developed for type 2 diabetes and moved into weight management as demand climbed worldwide. Celebrity disclosures about using them have become a live topic precisely because so many people have chosen to stay quiet about it.
Metz has kept the conversation on her own terms, framing the medication as one piece of a longer health journey rather than the whole story. Her ambassador work with the telehealth company was ongoing at the time of publishing, which suggests more updates are coming from her directly.
